PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50119C00022Advanced research and development of rvsv-marv — Public Health Vaccines LLC

Public Health Vaccines LLC holds $32.8M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Jan 31, 2029 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Public Health Vaccines LLC

Recipient

Jan 31, 2029

PoP end

$66.7M

Obligated

541714

NAICS

AN13

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

NONE

Contract number75A50119C00022

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

IncumbentPublic Health Vaccines LLC

UEISX5LJU3KWF93

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN13

Place of performanceCAMBRIDGE, MA

PoP end (current)Jan 31, 2029

Obligated$66.7M

ADVANCED RESEARCH AND DEVELOPMENT OF RVSV-MARV VACCINE. is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Public Health Vaccines LLC. Estimated value $89M ($66.7M obligated). Current period of performance ends Jan 31, 2029. Last award drew 1 bidder. Place of performance: CAMBRIDGE, MA.

ADVANCED RESEARCH AND DEVELOPMENT OF RVSV-MARV VACCINE.

Recompete timing

Public

● Expiring in 857 days

Current PoP ends Jan 31, 2029 (857 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Jul 31, 2027.

Bonuses end Sept 30

Want the durability read on 75A50119C00022? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Public Health Vaccines LLC — $32.8M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$32.8M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50119C00022?

75A50119C00022 (Advanced research and development of rvsv-marv) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $89M, currently held by Public Health Vaccines LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50119C00022?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50119C00022 to Public Health Vaccines LLC.

Who is the incumbent on 75A50119C00022?

Public Health Vaccines LLC is the incumbent with $32.8M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Jan 31, 2029.

When does Public Health Vaccines LLC’s 75A50119C00022 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 31, 2029. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75A50119C00022? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action Jun 8, 2026